Epithelial barrier dysfunction, type 2 immune response, and the development of chronic inflammatory diseases
Authors:
- 24 September 2024
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 91, 102493
Abstract
No abstract availableKeywords
This publication has 136 references indexed in Scilit:
- Association of Increased Serum Lipopolysaccharide, But Not Microbial Dysbiosis, With Obesity‐Related OsteoarthritisArthritis & Rheumatology, 2022
- Gut Microbiota Dysbiosis as One Cause of Osteoporosis by Impairing Intestinal Barrier FunctionCalcified Tissue International, 2021
- Heart Failure is Associated with Depletion of Core Intestinal MicrobiotaESC Heart Failure, 2017
- Dysbiosis a risk factor for celiac diseaseMedical Microbiology and Immunology, 2017
- Evidence of microbiota dysbiosis in chronic rhinosinusitisInternational Forum of Allergy & Rhinology, 2016
- Brief Report: Defining the Nasal Transcriptome in Granulomatosis With Polyangiitis (Wegener's)Arthritis & Rheumatology, 2015
- Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease†Hepatology, 2009
- Nontraumatic keratomycosis caused by Alternaria in a glaucoma patientInternational Ophthalmology, 2008
- Increased intestinal permeability precedes clinical onset of type 1 diabetesDiabetologia, 2006
- IgE Antibodies to Staphylococcus aureusArchives of Dermatology, 1985